Is Dupuytren's disease caused by an imbalance between proliferation and cell death?

Journal of Hand Surgery

Volumn 24 B, Issue 5, 1999, Pages 511-514

  Jemec, B ^a   Grobbelaar, A O ^a   Wilson, G D ^a   Smith, P J ^a   Sanders, R ^a   McGrouther, D A ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

ADULT; AGED; ARTICLE; CARPAL TUNNEL SYNDROME; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DUPUYTREN CONTRACTURE; FASCIA; FEMALE; FIBROSARCOMA; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; ONCOGENE C MYB;

EID: 0032757534     PISSN: 02667681     EISSN: None     Source Type: Journal    
DOI: 10.1054/jhsb.1999.0251     Document Type: Article

References (23)

1. Azzarone B, Failly-Crepin C, Daya-Grosjean L, Chapponier C, Gabbiani G (1983). Abnormal behaviour of cultured fibroblasts from nodule and nonaffected aponeurosis of Dupuytren's disease. Journal of Cellular Physiology, 117: 353-361.
2. Campisi J, Gray HE, Pardee AB, Dean M, Sonenshein GE (1984). Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell, 36: 241-247.
3. Diaz-Cascajo C, Bastida-Iñarrea J, Borrego L, Carretero-Hernández G (1995). Comparison between p53 expression in dermatofibrosarcoma protuberans and dermatofibroma: Lack of correlation with proliferation rate. Journal of Cutaneous Pathology, 22: 304-309.
4. Enzinger FM, Weiss SW. Soft tissue tumors, 3rd edn. St Louis, Mosby, 1995: 201.
5. Erdmann MWH, Quaba AA, Sommerlad BC (1995). Epithelioid sarcoma masquerading as Dupuytren's disease. British Journal of Plastic Surgery, 48: 39-42.
6. Evan GI, Littlewood TD (1993). The role of c-myc on cell growth. Current Opinions in Genetics and Development, 3: 44-49.
7. Gee JMW, Douglas-Jones A, Hepburn P et al. (1995). A cautionary note regarding the application of Ki-67 antibodies to paraffin-embedded breast cancers. Journal of Pathology, 177: 285-293.
8. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA (1983). Method for analysis of cellular DNA content of paraffin embedded pathological material using flow cytometry. Journal of Histochemistry and Cytochemistry, 31: 1333-1335.
9. Hockenberry DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ (1991). Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proceedings of the National Academy of Science USA, 88: 6961-6965.
10. Korsmeyer JS (1992). Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood, 80: 879-886.
11. Lopez F, Belloc F, Lacombe F et al. (1994). The labeling of proliferating cells by Ki-67 and Mib-I antibodies depends on the binding of a nuclear protein to the DNA. Experimental Cell Research, 210: 145-153.
12. Luck JV (1959). Dupuytren's contracture. A new concept of the pathogenesis correlated with surgical management. Journal of Bone and Joint Surgery, 41A: 635-664.
13. Meis-Kindblom JM, Enzinger FM (1996). Fibrous tissue tumours. In: Meis-Kindblom JM and Enzinger FM (Eds) Color atlas of soft tissue tumors. St Louis, Mosby-Wolfe, 1996: 35.
14. Myhre Jensen O, Høgh J, Østgaard SE, Munck Nordentoft A, Sneppen O (1991). Histopathological grading of soft tissue tumours. Prognostic significance in a prospective study of 278 cases. Journal of Pathology, 163: 19-24.
15. Oshiro Y, Fukuda T, Tsuneyoshi M (1995). Atypical fibroxanthoma versus benign and malignant fibrous histocytoma. Cancer, 75: 1128-1134.
16. Pardee AB (1989). G1 events and regulation of cell proliferation. Science, 246: 603-608.
17. Paulson OB, Gjerris F, Boysen GM, Olesen J (1986). Neurologiske sygdomme. In: Thayen JH, Korsgaard Christensen L, Lorenzen I (Eds). Medicinsk Kompendium, bind II. Copenhagen, Nyt Nordisk forlag Arnold Busck, 1986: 2195-2358.
18. Reed JC (1994). Bcl-2 and the regulation of programmed cell death. Journal of Cell Biology, 124: 1-6.
19. Takafumi U, Aozasa K, Tsujimoto M et al. (1989). Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer, 63: 1607-1611.
20. Ushijima M, Tsuneyoshi M, Enjoji M (1984). Dupuytren type fibromatoses. A clinicopathological study of 62 cases. Acta Pathologica Japonica, 34: 991-1001.
21. Wagner AJ, Small MB, Hay N (1993). Myc-medidated apoptosis is blocked by ectopic expression of Bcl-2. Molecular and Cellular Biology, 13: 2432-2440.
22. Williams GT, Smith CA, McCarthy NJ, Grimes EA (1992). Apoptosis final control point in cell biology. Trends in Cell Biology, 2: 263-267.
23. Wilutzky B, Berndt A, Katenkamp D, Kosmehl H (1998). Programmed cell death in nodular palmer fibromatosis (Morbus Dupuytren). Histology and Histopathology, 13: 67-72.